Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Isabel Fort-Gallifa"'
Autor:
Elisabet Rodríguez-Tomàs, Mauricio Murcia, Meritxell Arenas, Mònica Arguís, Miriam Gil, Núria Amigó, Xavier Correig, Laura Torres, Sebastià Sabater, Gerard Baiges-Gayà, Noemí Cabré, Fedra Luciano-Mateo, Anna Hernández-Aguilera, Isabel Fort-Gallifa, Jordi Camps, Jorge Joven
Publikováno v:
Antioxidants, Vol 8, Iss 7, p 213 (2019)
We investigated alterations in the levels of the antioxidant paraoxonase-1 (PON1) and the lipoprotein profile (analyzed by nuclear magnetic resonance) in patients with lung cancer (LC) or head and neck cancer (HNC), and the effects produced thereon b
Externí odkaz:
https://doaj.org/article/bfc5710b05804533893087fa184c15bf
Autor:
Núria Amigó, Isabel Fort-Gallifa, Xavier Correig, Fedra Luciano-Mateo, Laura Torres, Meritxell Arenas, Miriam Gil, Mauricio Murcia, Elisabet Rodríguez-Tomàs, Jorge Joven, Jordi Camps, Sebastià Sabater, Noemí Cabré, Monica Arguís, Anna Hernández-Aguilera, Gerard Baiges-Gaya
Publikováno v:
Antioxidants, Vol 8, Iss 7, p 213 (2019)
Antioxidants
Volume 8
Issue 7
Antioxidants
Volume 8
Issue 7
We investigated alterations in the levels of the antioxidant paraoxonase-1 (PON1) and the lipoprotein profile (analyzed by nuclear magnetic resonance) in patients with lung cancer (LC) or head and neck cancer (HNC), and the effects produced thereon b
Autor:
Jorge Joven, Anabel García-Heredia, Marta Riera-Borrull, Isabel Fort-Gallifa, Fedra Luciano-Mateo, Noemí Cabré, Anna Hernandez-Aguilera, Jordi Camps
Publikováno v:
Chemico-Biological Interactions
Repositori Institucional de la Universitat Rovira i Virgili
Universitat Rovira i virgili (URV)
Repositori Institucional de la Universitat Rovira i Virgili
Universitat Rovira i virgili (URV)
Metformin is the first-line pharmacological treatment of diabetes. In these patients, metformin reduces body weight and decreases the risk of diabetes-related complications such as cardiovascular disease. However, whether metformin elicits beneficial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::bf3fda7f2a772dfb8b4f8ad91a4d7825
http://hdl.handle.net/20.500.11797/PC1546
http://hdl.handle.net/20.500.11797/PC1546
Autor:
Jorge Joven, Jordi Camps, Isabel Fort-Gallifa, Noemí Cabré, Fedra Luciano-Mateo, Anna Hernández-Aguilera, Anabel García-Heredia, Marta Riera-Borrull
Publikováno v:
Chemico-Biological Interactions
Metformin is the first-line pharmacological treatment of diabetes. In these patients, metformin reduces body weight and decreases the risk of diabetes-related complications such as cardiovascular disease. However, whether metformin elicits beneficial